Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial | Trials | Full Text

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial | Trials | Full Text

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial

Safety data is required to be collected in all clinical trials and can be separated into two types of data, adverse events and serious adverse events. Often, these types of safety data are collected as two dis...

Authors:Elizabeth C. James, David Dunn, Adrian D. Cook, Andrew R. Clamp and Matthew R. Sydes

Citation:Trials 2020 21:802

Content type:Methodology

 

Published on: 17 September 2020

• ViewFull Text
 
• ViewPDF